Article
The Metabolic Bone Disease X-Linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology
2021-05-10
Abstract excerpt
The authors present a stereotypical case presentation of x-linked hypophosphatemia (XLH) and provide a review of the pathophysiology and related pharmacology of this condition, primarily focusing on the FDA-approved medication burosumab. XLH is a renal phosphate wasting disorder caused by loss of function mutations in the PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X chromosome)....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b09c8f7c-ce78-5f63-b224-522af1ebe013
- DOI
- 10.20944/preprints202105.0202.v1
